CN1319021A - 联合治疗中的趋化因子受体拮抗剂和环孢菌素 - Google Patents
联合治疗中的趋化因子受体拮抗剂和环孢菌素Info
- Publication number
- CN1319021A CN1319021A CN99811125A CN99811125A CN1319021A CN 1319021 A CN1319021 A CN 1319021A CN 99811125 A CN99811125 A CN 99811125A CN 99811125 A CN99811125 A CN 99811125A CN 1319021 A CN1319021 A CN 1319021A
- Authority
- CN
- China
- Prior art keywords
- rantes
- cyclosporin
- chemokine receptor
- cell
- met
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
对照(n=9) | Met-RANTES(n=9) | |
体重(g) | 211.8±5.15 | 195±5.98 |
移植肾脏重量 | 1.41±0.048 | 1.15±0.08* |
内源肾脏重量 | 0.91±0.04 | 0.8±0.04 |
肾小球中的T细胞 | 3.98±0.81 | 2.75±0.45 |
肾小球中的巨噬细胞 | 9.16±1.69 | 5.98±0.87 |
血管损伤 | 肾小管损伤 | 间质炎症 | ||||
对照 | Met-RANTES | 对照 | Met-RANTES | 对照 | Met-RANTES | |
0级 | 50.67±9.02 | 85.5±2.66 | 15.56±6.03 | 46.00±12.15 | 1.39±1.11 | 16.00±7.14 |
1级 | 40.44±5.5 | 12.8±4.17 | 32.22±8.25 | 30.00±6.06 | 44.17±12.39 | 58.00±8.7 |
2级 | 4.44±2.22 | 0.9±0.6 | 20.56±5.68 | 13.00±4.1 | 18.33±5.95 | 9.50±4.62 |
3级 | 5.55±5.55 | 0±0.0 | 31.67±14.19 | 8.50±7.46 | 36.11±14.88 | 10.50±9.44 |
评分 | 62.67±18.64 | 16.1±5.2* | 33.00±6.44 | 15.70±5.22 | 37.78±5.58 | 24.45±4.62 |
评分 | 环孢菌素2.5mg/kg b.w./d | 环孢菌素2.5mg/kg b.w./d+Met-RANTES50微克/日 |
血管损伤 | 60.7±1.8 | 13.7±7.5* |
肾小管损伤 | 124.3±28.7 | 28.3±14.8* |
间质炎症 | 157.3±21.3 | 71±6.1* |
SMFI(通道) | 对照 | IL-1β | |
ICAM-1 | 实验1 | 339 | 502 |
实验2 | 386 | 592 | |
实验3 | 327 | 432 | |
VCAM-1 | 实验1 | 10 | 76 |
实验2 | 72 | 236 | |
实验3 | 25 | 129 | |
E-选择素 | 实验1 | 1 | 120 |
实验2 | 44 | 265 | |
实验3 | 28 | 177 |
Claims (16)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98117697A EP1000626A1 (en) | 1998-09-18 | 1998-09-18 | Chemokine receptor antagonist and cyclosporin in combined therapy |
EP98117697.7 | 1998-09-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1319021A true CN1319021A (zh) | 2001-10-24 |
CN1177613C CN1177613C (zh) | 2004-12-01 |
Family
ID=8232654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB998111252A Expired - Fee Related CN1177613C (zh) | 1998-09-18 | 1999-09-16 | 联合治疗中的趋化因子受体拮抗剂和环孢菌素 |
Country Status (23)
Country | Link |
---|---|
US (1) | US6902728B1 (zh) |
EP (2) | EP1000626A1 (zh) |
JP (1) | JP2003519082A (zh) |
KR (1) | KR100613950B1 (zh) |
CN (1) | CN1177613C (zh) |
AR (1) | AR021810A1 (zh) |
AT (1) | ATE227582T1 (zh) |
AU (1) | AU766595B2 (zh) |
BR (1) | BR9913846A (zh) |
CA (1) | CA2344370A1 (zh) |
DE (1) | DE69903964T2 (zh) |
DK (1) | DK1113811T3 (zh) |
EA (1) | EA003181B1 (zh) |
EE (1) | EE04705B1 (zh) |
ES (1) | ES2186411T3 (zh) |
HK (1) | HK1041225B (zh) |
IL (2) | IL141899A0 (zh) |
NO (1) | NO20011371L (zh) |
PT (1) | PT1113811E (zh) |
SI (1) | SI1113811T1 (zh) |
UA (1) | UA60379C2 (zh) |
WO (1) | WO2000016796A1 (zh) |
ZA (1) | ZA200101909B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7259136B2 (en) | 1999-04-30 | 2007-08-21 | Amylin Pharmaceuticals, Inc. | Compositions and methods for treating peripheral vascular disease |
US6740636B2 (en) * | 2000-07-31 | 2004-05-25 | Schering Aktiengesellschaft | Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection |
LT5132B (lt) | 2000-07-31 | 2004-05-25 | Schering Aktiengesellschaft | Nepeptidiniai ccr1 receptorių antagonistai derinyje su ciklosporinu a širdies transplanto atmetimui gydyti |
EP2185719B1 (en) | 2007-08-02 | 2013-11-13 | NovImmune SA | Anti-rantes antibodies and methods of use thereof |
DE112016003948T5 (de) | 2015-08-31 | 2018-05-09 | City Of Sapporo | Molekulare verfahren zum beurteilen einer urothelialen erkrankung |
US20180265914A1 (en) * | 2015-08-31 | 2018-09-20 | Hitachi Chemical Co., Ltd. | Molecular methods for assessing post kidney transplant complications |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1087346C (zh) * | 1994-12-08 | 2002-07-10 | 格拉克索公司 | 用于炎症治疗的rantfs肽和片段及包括它们的组合物 |
WO1997005896A1 (en) * | 1995-08-09 | 1997-02-20 | Schering Corporation | Combined use of interleukin-10 and cyclosporin for immunosuppression therapy |
US6184235B1 (en) * | 1996-08-14 | 2001-02-06 | Warner-Lambert Company | 2-phenyl benzimidazole derivatives as MCP-1 antagonists |
WO1998006751A1 (en) * | 1996-08-16 | 1998-02-19 | Research Corporation Technologies, Inc. | Mcp-3, rantes and mip-1alpha receptor antagonists |
-
1998
- 1998-09-18 EP EP98117697A patent/EP1000626A1/en not_active Withdrawn
-
1999
- 1999-09-16 UA UA2001042570A patent/UA60379C2/uk unknown
- 1999-09-16 CA CA002344370A patent/CA2344370A1/en not_active Abandoned
- 1999-09-16 SI SI9930157T patent/SI1113811T1/xx unknown
- 1999-09-16 ZA ZA200101909A patent/ZA200101909B/xx unknown
- 1999-09-16 IL IL141899??A patent/IL141899A0/xx active IP Right Grant
- 1999-09-16 WO PCT/EP1999/006844 patent/WO2000016796A1/en active IP Right Grant
- 1999-09-16 AU AU61914/99A patent/AU766595B2/en not_active Ceased
- 1999-09-16 EP EP99948760A patent/EP1113811B1/en not_active Expired - Lifetime
- 1999-09-16 ES ES99948760T patent/ES2186411T3/es not_active Expired - Lifetime
- 1999-09-16 AR ARP990104655A patent/AR021810A1/es unknown
- 1999-09-16 BR BR9913846-8A patent/BR9913846A/pt not_active Application Discontinuation
- 1999-09-16 EA EA200100366A patent/EA003181B1/ru not_active IP Right Cessation
- 1999-09-16 KR KR1020017003199A patent/KR100613950B1/ko not_active IP Right Cessation
- 1999-09-16 EE EEP200100159A patent/EE04705B1/xx not_active IP Right Cessation
- 1999-09-16 AT AT99948760T patent/ATE227582T1/de active
- 1999-09-16 PT PT99948760T patent/PT1113811E/pt unknown
- 1999-09-16 US US09/787,335 patent/US6902728B1/en not_active Expired - Fee Related
- 1999-09-16 CN CNB998111252A patent/CN1177613C/zh not_active Expired - Fee Related
- 1999-09-16 DK DK99948760T patent/DK1113811T3/da active
- 1999-09-16 JP JP2000573757A patent/JP2003519082A/ja not_active Withdrawn
- 1999-09-16 DE DE69903964T patent/DE69903964T2/de not_active Expired - Lifetime
-
2001
- 2001-03-08 IL IL141899A patent/IL141899A/en not_active IP Right Cessation
- 2001-03-16 NO NO20011371A patent/NO20011371L/no not_active Application Discontinuation
-
2002
- 2002-04-23 HK HK02103034.0A patent/HK1041225B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EE200100159A (et) | 2002-08-15 |
ES2186411T3 (es) | 2003-05-01 |
HK1041225A1 (en) | 2002-07-05 |
EP1000626A1 (en) | 2000-05-17 |
NO20011371D0 (no) | 2001-03-16 |
EE04705B1 (et) | 2006-10-16 |
BR9913846A (pt) | 2001-06-05 |
SI1113811T1 (en) | 2003-04-30 |
CA2344370A1 (en) | 2000-03-30 |
DE69903964T2 (de) | 2003-03-27 |
KR100613950B1 (ko) | 2006-08-18 |
DK1113811T3 (da) | 2003-03-10 |
AU766595B2 (en) | 2003-10-16 |
JP2003519082A (ja) | 2003-06-17 |
EP1113811B1 (en) | 2002-11-13 |
EA003181B1 (ru) | 2003-02-27 |
ZA200101909B (en) | 2001-09-11 |
EP1113811A1 (en) | 2001-07-11 |
AU6191499A (en) | 2000-04-10 |
US6902728B1 (en) | 2005-06-07 |
WO2000016796A1 (en) | 2000-03-30 |
PT1113811E (pt) | 2003-03-31 |
ATE227582T1 (de) | 2002-11-15 |
HK1041225B (zh) | 2005-04-22 |
DE69903964D1 (en) | 2002-12-19 |
KR20010075060A (ko) | 2001-08-09 |
UA60379C2 (uk) | 2003-10-15 |
IL141899A0 (en) | 2002-03-10 |
CN1177613C (zh) | 2004-12-01 |
AR021810A1 (es) | 2002-08-07 |
IL141899A (en) | 2007-12-03 |
NO20011371L (no) | 2001-03-16 |
EA200100366A1 (ru) | 2001-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gröne et al. | Met‐RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment | |
Kuan et al. | Collecting lymphatic vessel permeability facilitates adipose tissue inflammation and distribution of antigen to lymph node–homing adipose tissue dendritic cells | |
Emeson et al. | T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. | |
Duffield et al. | Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair | |
Pollitt et al. | A scanning electron microscopical study of the dermal microcirculation of the equine foot | |
DeBruyne et al. | Gene transfer of virally encoded chemokine antagonists vMIP-II and MC148 prolongs cardiac allograft survival and inhibits donor-specific immunity | |
Miura et al. | ROLE OF HYPOMAGNESEMIA IN CHRONIC CYCLOSPORINE NEPHROPATHY1 | |
CN101553244B (zh) | 内膜增生和相关病状的治疗 | |
MX2007009235A (es) | Composiciones y metodos para tratar desordenes fibroticos. | |
CN1681526A (zh) | 促红细胞生成素的应用 | |
CN1671742A (zh) | Hmgb1在治疗组织损伤和/或促进组织修复中的用途 | |
WO2001078708A1 (en) | Treating graft rejection with cxcr3 inhibitors | |
Kondo et al. | EARLY INCREASED CHEMOKINE EXPRESSION AND PRODUCTION IN MURINE ALLOGENEIC SKIN GRAFTS IS MEDIATED BY NATURAL KILLER CELLS1 | |
CN1177613C (zh) | 联合治疗中的趋化因子受体拮抗剂和环孢菌素 | |
Van Eeden et al. | Interleukin 8 (IL-8) and the release of leukocytes from the bone marrow | |
Akita et al. | Leukemia inhibitory factor gene improves skin allograft survival in the mouse model1 | |
CN101356190A (zh) | 用于抑制pf4和rantes相互作用的拮抗剂 | |
US20090131329A1 (en) | Treatment for allograft rejection | |
Massfelder et al. | Type 1 parathyroid hormone receptor expression level modulates renal tone and plasma renin activity in spontaneously hypertensive rat | |
WO2017189480A1 (en) | Compositions and methods for grafts modified with a non-thrombogenic and pro-migratory cell-derived extracellular matrix | |
Lukacs et al. | Adhesion molecules, cytokines, and chemokines in allergic airway inflammation | |
JP2002535358A (ja) | 移植片拒絶反応及び虚血−再灌流障害の予防方法 | |
El-Awaisi | Investigating a novel role for the IL-36/IL-36R pathway in mediating inflammation in the adult and aged murine heart after ischaemia-reperfusion injury | |
Gerdes | The role of the pro-inflammatory cytokine Interleukin-18, its processing enzyme Caspase-1, and potential alternative IL-18-activating pathways in atherosclerosis | |
WO2010051347A1 (en) | A method for cardioprotection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1041225 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: SERONO LABORATORY CO., LTD. Free format text: FORMER OWNER: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. Effective date: 20080516 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20080516 Address after: Swiss Coyne Hince Patentee after: Serono Lab Address before: Curacao, Netherlands Antilles Patentee before: Applied Research Systems ARS Holding N. V. |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041201 Termination date: 20091016 |